Chemotherapy Drugs Flashcards
1
Q
Mechlorethamine:
- Class
- Mechanism
- Cell Cycle Profile
- Therapeutic Uses
- Special details (about it’s metabolism and administration)
A
- Alkylating Agent
- Cross links DNA to block replication and txn
- CCNS
- Hodgkin’s Lymphoma (MOPP)
- This drug is not excreted, and must be given IV
2
Q
Cyclophosphamide:
- Class
- Mechanism
- what is the exact binding site?
- Cell Cycle Profile
- How does this drug become activated?
- Toxicity
- What drug is administered to manage toxicity??? How does this drug work?
- Uses
A
- Alkylating Agent
- Cross links DNA to block replication and txn, *binds Guanine N-7
- CCNS
- The liver activates Cyclophosphamide and iphosphamide using a cytochrome P450; this oxidative activation cleaves off Acrolein, opening the molecule for DNA binding.
- Hemorrhagic cystitis, SIADH
- MESNA, it binds to Acrolein
- Burkitt’s lymphoma, acute lymphocytic leukemia, autoimmune diseases
3
Q
Chlorambucil:
- Class
- Mechanism
- Cell Cycle Profile
- Toxicity
- Uses
A
- Alkylating Agent
- Cross links DNA to block replication and txn, *binds Guanine N-7
- CCNS
- Hepatotoxicity
- chronic lymphocytic leukemia
4
Q
Estramustine Phosphate:
- This drug is a mustard + ___ (look at the name).
- Mechanism
- what about the mechanism sets this drug apart from others in its class?
- Cell Cycle Profile
- Route of administration and activation
- when is this drug used?
A
- estradiol
- binds to beta tubulin
- works as an anti mitotic rather than alkylating agent
- CCNS: M
- given orally, phosphate cleaved during absorption
- used as palliative treatment in metastatic or progressive prostate cancer
5
Q
Busulfan:
- Class (not a nitrogen mustard)
- Cell Cycle Profile
- Toxicity
- Use, what’s the drawback?
A
- bis-methyl sulfonate
- CCNS
- pulmonary fibrosis and hyper pigmentation of the skin
- CML, only extends life by ~9 months
6
Q
Carmustine (BCNU), Lomustine (CCNU), Semustine (methyl-CCNU)
- Class
- Cell Cycle Profile
- Toxicity
- What’s so special about these drugs that makes them first line treatment for brain tumors???
- what’s released when these drugs are broken down?
A
- Nitrosoureas
- CCNS
- pulmonary fibrosis and nephrotoxicity
- they’re highly lipophilic
- breakdown in vivo liberates alkylating and carbamylating species
7
Q
Procarbazine (Mulatane, MOPP):
- Class
- Cell Cycle Profile
- mechanism
- Special Details (hint: this is an MAO inhibitor)
A
- Nitrosourea
- CCNS
- react covalently with nucleic acids, decreasing DNA, RNA, protein synthesis, and inhibiting G1 to S transition
- avoid use with MAOIs and alcohol
8
Q
Dacarbazine (DTIC), Temozolomide (T):
- Class
- Mechanism
- Cell Cycle Profile
A
- Nitrosourea
- methylates DNA and RNA
- CCNS
9
Q
Cisplatin:
- Class
- Mechanism
- Cell Cycle Profile
- Toxicity
- *What drug can you give to control this toxicity?
- Which drugs should you never prescribe with a platin?
- name two drugs of the same class that are less toxic
A
- Platinum-containing drug
- Binds to guanine, forming intrastrand crosslinks
- CCNS
- nephrotoxicity and ototoxicity, peripheral neuropathy
- *furosemide, causes forced diuresis and improves renal clearance, also prevent with amifostine and chloride diuresis
- Aminoglycosides
- Oxaliplatin, Carboplatin
10
Q
Doxorubicin:
- class
- which enzyme
- mechanism
- cell cycle profile
- toxicity
- *which drug controls this toxicity
- uses
- name one other drug with a similar mechanism, but is less cardiotoxic
A
- anthracycline
- topoisomerase ii
- intercalates DNA, causes single and double stranded breaks, inhibits repair, *histone eviction
- CCNS
- cardiotoxicity
- *controlled with dexrazoxane
- breast cancer, sarcoma, MOPP-resistant Hodgkin’s (Anthracyline-BVD)
- Epirubicin
11
Q
Daunorubicin:
- class
- which enzyme
- mechanism
- cell cycle profile
- toxicity
- name one other drug with a similar mechanism, but is less cardiotoxic
A
- anthracycline
- topoisomerase ii
- intercalates DNA, causes single and double stranded breaks, inhibits repair, *histone eviction
- CCNS
- cardiotoxicity
- Idarubicin
12
Q
Mitoxantrone:
- which enzyme
- mechanism
- how is this drug’s mechanism different from Doxorubicin
- cell cycle profile
- toxicity
A
- topoisomerase ii
- intercalates DNA, causes single and double stranded breaks, inhibits repair, histone eviction
- does NOT form free radicals
- CCNS
- cardiotoxicity, lower than doxo or daunorubicin
13
Q
Epipodophyllotoxins (Etoposide + Tenopside):
- which enzyme
- mechanism
- cell cycle profile
- therapeutic uses
A
- topoisomerase ii
- forms ternary complex, prevents re-ligation of DNA strands
- CCS: S and G2
- testicular, small cell lung cancer
14
Q
Camptothecin, Topotecan, Irinotecan:
- class
- which enzyme
- mechanism
- cell cycle profile
- toxicity
A
- camptothecin analogs
- topoisomerase i
- forms ternary complex
- CCS: S
- severe diarrhea
15
Q
Bleomycins:
- drug class
- mechanism
- cell cycle profile
- toxicity
- therapeutic uses
A
- antibiotic
- bind reduced iron in cells and cause free radical production
- CCS: G2
- pulmonary fibrosis, minor myelosuppression, cutaneous reactions, low grade fever
- advanced testicular carcinoma
16
Q
Dactinomycin:
- drug class
- mechanism
- cell cycle profile
- toxicity
- therapeutic uses
A
- antibiotic
- intercalate DNA, prevent transcription, single strand DNA breaks
- CCNS
- oral and GI ulceration, stomatitis
- methotrexate resistant choriocarcinoma, Wilm’s tumor, Rhabdomyosarcoma, Ewing’s sarcoma, gestational trophoblastic malignancy
17
Q
Streptozocin
- class
- primary use
- toxicity
A
- nitrosoureas, this one was listed with carmustine and lomustine for some reason
- pancreatic cancer
- pulmonary fibrosis and nephrotoxicity
18
Q
Methotrexate
- Class
- Mechanism
- Cell cycle profile
- Toxicity
- what drug is administered with MTX and why?
A
- folic acid analog
- inhibits dihydrofolate reductase, blocks synthesis of thymidylate and purines
- CCS: S
- mucositis: oral and GI ulceration, hepatotoxicity, pulmonary toxicity
- Leucovorin, doesn’t need DHF reductase to become active THF, saves the body from myelosuppression
19
Q
5-Fluorouracil
- Class
- Mechanism
- Cell cycle profile
- Toxicity
A
- pyrimidine analog
- inhibits thymidylate synthase, incorporates into DNA and RNA
- CCNS; G1, S
- oral and GI ulceration
20
Q
Cytarabine, Cytosar
- Class
- Mechanism
- Cell cycle profile
- Toxicity
A
- pyrimidine analog
- inhibit DNA pol alpha, incorporate into DNA
- CCS: S
- oral ulceration
21
Q
Gemcitabine
- Class
- Mechanism
- Cell cycle profile
A
- pyrimidine analog
- inhibits DNA synthesis with many mechanisms
- CCNS
22
Q
Mercaptopurine
- Class
- Mechanism
- Cell cycle profile
- Toxicity
- Which drug inhibits the activity of mercaptopurine?
A
- purine analog
- inhibits synthesis of adenine and guanine by blocking conversion of insinuate to purine precursors
- CCS: S
- cholestasis, oral and intestinal ulcers
- allopurinol
23
Q
Cladribine, Fludarabine
- Class
- Mechanism
- Use
A
- ADA inhibitor
- blocks conversion of adenosine to inosine, buildup of dATP leads to cellular toxicity, no DNA synthesis
- hairy cell leukemia
24
Q
Vincristine, Vinblastine, vinorelbine
- Class
- Mechanism
- Cell cycle profile
- Toxicity
A
- Vinca Alkaloid
- binds to soluble tubulin, inhibits assembly of mitotic spindle during metaphase of mitosis
- CCS: M
- peripheral neuropathy, alopecia, nephrogenic SIADH secretion, myelosuppression
25
Paclitaxel (taxol), Docetaxel
- Class
- Mechanism
- Cell cycle profile
- Toxicity
- Yew alkaloid
- binds to polymerized microtubule and prevents depolymerization
- CCS: M
- peripheral neuropathy (dose limiting)
26
IFN-alpha
- Class (really obvious)
- Mechanism
- Cell cycle profile
- cytokine (duh.)
- inhibits tumor growth via host immune system, has some direct activity
- CCNS, slows the progression through the cell cycle
27
Prednisone:
- Class
- Mechanism
- Therapeutic uses
- hormone
- anti-inflammatory, causes apoptosis in leukemic cells
- Hodgkin's lymphoma (MOPP), acute leukemias, relapsed hairy cell lymphoma
28
synthetic progesterone and it's derivatives
- Class
- Mechanism
- uses
- progestin
- used in hormone responsive cancers expressing progesterone receptor, blocks progesterone from binding and ceases growth
- post surgical endometrial carcinoma and metastatic renal cancer
29
Tamoxifen, toremifine
- Class
- Therapuetic use (hint: they're hormonal)
* which is not a steroid?
- anti-estrogens
- used in estrogen receptor positive breast and lung cancer
* tamoxifen is not a steroid
30
Casodex, eulixin, nilandron
- Class
- Mechanism
- what do you combine them with for total ablation?
- anti-androgens
- prevent tes and dihydrotes from binding to the cancer cell
- leuprolide, which is an LHRH agonist and keeps LH from being released, thereby decrease tes production
31
Bevuczimab (avastin)
- Class
- Mechanism
- antibody
| - blocks VEGF-R and prevents angiogenesis
32
Denusomab
- Class
- Mechanism
- antibody
| - blocks RANK/RANKL in bone (think dense-usomab)
33
Trastuzumab
- Class
- Mechanism
- antibody
| - blocks HER-2 positive breast and gastric cancers
34
Imatinib (Gleevac)
- Class
- Mechanism
- Therapeutic uses
- targeted inhibitor
- blocks the BCR-ABL kinase protein resulting from the Philadelphia chromosome
- CML
35
Erlotinib, Gefitinib
- Class
- Mechanism
- targeted inhibitor
| - blocks EGFR signaling
36
Crizotinib
- Class
- Mechanism
- Therapeutic uses
- targeted inhibitor
- blocks ALK-1 kinase
- non small cell lung cancer (10% of pts are positive for ALK-1)
37
Venetoclax
- Class
- Mechanism
- Therapeutic uses
- anti-apoptotic inhibitor
- binds Bcl-2 and
- refractory chronic lymphocytic leukemia
38
Vorinostat, Romidepsin
- Class
- Mechanism
- epigenetic signaling
| - histone deacetylase (HDAC) inhibition (keeps the chromatin in tight conformation)
39
OLAPARIB
- Class (which process within the cell does it target?)
- Mechanism
- target DNA repair
| - PARP-1 inhibitor
40
Amirubicin
- Class
- Advantage
- anthracylin (like doxorubicin)
| - reduced cardiotoxicity
41
Fulvestrant
- Class
- Advantage
- estrogen receptor blocker
| - lacks partial receptor activity, useful for estrogen responsive cancers
42
Abraxane
- Class
- Advantage
- IV nanoparticle, paclitaxel bounds to albumin
| - cremophor-free (cremephor is a previously used vehicle known to cause anaphylaxis)
43
Picoplatin
- Class
- Advantage
- platinum containing
| - doesn't cause platinum resistance
44
- Why do cancer cells (and cells in general) take up Melphalan? (what is it about this drug's structure?
- Also, how does Melphalan cause cell death?
- Melphalan has a phenylalanine side chain
| - Attached to the side chain is a nitrogen mustard, which cross-links (alkylates) guanines at the N-7 position.
45
which drug should be avoided with EtOH?
Procarbazine (don't drink and drive the Pro-car)
46
which drug inhibits ribonucleotide reductase?
hydroxyurea